First human test for new drug begins
NCT ID NCT07374406
Summary
This is the first study in people for a new drug called Epaminurad. It aims to see how the drug moves through the body and if it is safe. The study involves 34 healthy adult volunteers who will take a single dose while fasting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jeonbuk National University Hospital
RECRUITINGJeonju, South Korea
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.